IMGM Laboratories offers advanced genomic services focusing on METAGENOMICS, BIOMARKER DISCOVERY, BIODISTRIBUTION and PHARMACOGENETICS. As a service provider, we tailor each project design to the needs of our customers coming from pharma, diagnostics, biotech, clinics and academia.
Our broad technology portfolio includes:
- Next Generation Sequencing with Illumina MiSeq, NextSeq500 and HiSeq2500, Roche 454 GS Junior+ and FLX+ and Ion Torrent PGM
- Microarray Analysis on Agilent and Affymetrix platform
- qPCR with TaqMan technology on ViiA7 platform
Before each project, we provide a free of charge consulting in which we make sure to understand what exactly you want to achieve with the analysis, and advise you on the best approach. After the analysis, expert bioinformatics and comprehensive reporting written in publication style complete our services. IMGM is certified service provider for Agilent, Affymetrix, and Ion Torrent PGM and holds an ISO 17025 accreditation for Sanger sequencing as well as for gene expression analysis and SNP genotyping using both real-time PCR and microarray technology.
Whether you are interested in 16S rRNA or whole genome sequencing, RNA-Seq or targeted re-sequencing, gene expression analysis, detection of SNPs and CNVs or our other genomic services: we are looking forward to get in touch with you. For more information on IMGM’s service portfolio please visit www.IMGM.com.